REACH

Strategic Advisory Group

ABOUT

REACH

Strategic Advisory Group

The Refugees and Migrants in Europe – Adolescent and Child Health (REACH) group is an official Strategic Advisory Group of the EAP (European Academy of Paediatrics, Paediatric section of UEMS) which has been established in 2023 to promote health equity for pediatric migrants in Europe.


The group’s vision is that across Europe, migrants and refugees receive equitable quality of health care compared to their local peers, both in terms of access to and continuity of care. Further, paediatric migrant and refugee patients and their caregivers have equitable opportunities to communicate and build trusted relationships with health care professionals and collaborating disciplines.


To reach this vision, the group aims to assess, monitor and improve the health of paediatric migrants/refugees across Europe through interdisciplinary collaboration in the areas of education, research, and advocacy.

Leadership

Julia Brandenberger

Chair

Division of Paediatric Emergency Medicine, Department of Paediatrics, Inselspital, University Hospital Bern, Switzerland

Ruud Nijman

Co – Chair

Division of Medicine, Department of Paediatric Emergency Medicine, St. Mary’s Hospital – Imperial College NHS Healthcare Trust, London, United Kingdom

Join Us

With REACH in Making a Difference

Are you an Eastern European paediatrician or a double expert passionate about migrant health? We invite you to join our Participatory Steering Committee (PSP) and contribute to shaping the future of paediatric migrant health research and advocacy. Contact us to learn more about how you can get involved!


REACH puts emphasis on migrant participation in all its activities. It follows an open tent approach and invites interested migrants and/or migrant health workers to participate in its bimonthly online meetings and projects.

To Participate:

Write to us at

Presentations

REACH Strategic Advisory Group

Spring Meeting 2024

Porto, Portugal

Winter Meeting 2023

Brussels, Belgium

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative: